Athira Pharma Reports Full Year 2023 Financial Results and Pipeline and Business Updates wallstreet-online.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from wallstreet-online.de Daily Mail and Mail on Sunday newspapers.
Completed enrollment in Phase 2/3 LIFT-AD clinical trial of fosgonimeton as a potential treatment for mild-to-moderate Alzheimer’s disease and expects topline data in second half of 2024 Plans to.
The Inner Circle Acknowledges, Arun Kumar Sherma as a Pinnacle Life Member for his contributions to the field of Internal Medicine streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.
/PRNewswire/ Prominently featured in The Inner Circle, Arun Kumar Sherma is acknowledged as a Pinnacle Life Member for his contributions to the field of.
Phase 2/3 LIFT-AD trial of fosgonimeton for mild-to-moderate Alzheimer’s disease to focus on 40 mg dose Open label extension trial to be extended, providing up to 36 months of long-term. | May 11, 2023